Please assess the completion status of the following clinical trial:

Trial Title: Individual Versus Standard Follicle Stimulating Hormone Dose for Controlled Ovarian Stimulation and Insemination

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 25-39 years~* First stimulation with rFSH only~* Indication for intrauterine insemination with standard rFSH starting dose~* Regular menstrual bleeding with a cycle between 21-35 days~* Two ovaries~* Bilateral tuba patency~* Semen analysis must be sufficient for insemination according to the diagnostic analysis.~Exclusion Criteria:~* More than three former stimulated intrauterine insemination cycles

- Gender: FEMALE
- Minimum Age: 25 Years
- Maximum Age: 39 Years
- Healthy Volunteers: f

Study Arms:
- Individual or standard rFSH dose (Type: ACTIVE_COMPARATOR): Patients were randomized to recieve individual (50, 75 or 100 IU/day) or standard (75 IU/day) rFSh dose. The individual dose was prescribed according to a dosage nomogram based on the patient's body weight (kg) and the total antral follicle count (Freiesleben NC et al., RBMOnline 2009;17:632-64).
- Standard rFSH dose (Type: ACTIVE_COMPARATOR): Standard dose of rFSH

Based on this trial design, predict the completion outcome and termination type (if applicable).